Skip to main content

Table 4 Laboratory Markers in hospitalised COVID-19 patients with the severe and non-severe groups

From: Clinical and laboratory characteristics of patients hospitalised with COVID-19: clinical outcomes in Abu Dhabi, United Arab Emirates

Variables

Overall (mean ± SD)

Severe (mean ± SD)

Non-severe (mean ± SD)

P-value

While blood cell count (× 109/L)

6.76 ± 3.69

7.02 ± 3.98

6.74 ± 3.66

0.0635

Lymphocyte count (× 109/L)

1.86 ± 2.72

1.79 ± 0.80

1.89 ± 2.84

0.0056

Neutrophil count (× 109/L)

4.22 ± 2.36

4.73 ± 03.71

4.17 ± 2.17

 < 0.0001

Creatinine (µmol/L)

88.32 ± 85.61

104.78 ± 124.10

86.72 ± 80.73

 < 0.0001

HbA1c (%)

7.81 ± 2.50

8.42 ± 2.38

7.77 ± 2.50

0.0591

LDH (IU/L)

264.46 ± 128.50

310.10 ± 182.50

259.76 ± 120.62

 < 0.0001

Ferritin (mcg/L)

555.95 ± 821.86

768.05 ± 1003.73

534.46 ± 798.09

 < 0.0001

CRP (mg/L)

29.51 ± 53.16

56.55 ± 86.87

26.83 ± 47.75

 < 0.0000

IL-6 (pg/mL)

158.84 ± 734.08

472.65 ± 1508.39

78.46 ± 255.48

 < 0.0000